Cleavage of bleomycin hydrolase by caspase-3 during apoptosis

Chen,Yang; Xu,Rong; Chen,Jianguo; Li,Xiaoyu; He,Qiyang

doi:10.3892/or.2013.2484

Cleavage of bleomycin hydrolase by caspase-3 during apoptosis

Authors:
- Yang Chen
- Rong Xu
- Jianguo Chen
- Xiaoyu Li
- Qiyang He
View Affiliations

Affiliations: Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, P.R. China
Published online on: May 23, 2013 https://doi.org/10.3892/or.2013.2484
Pages: 939-944

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Bleomycin hydrolase (BLH) affects bleomycin chemotherapy through inactivation of bleomycin with deamination. As a neutral cysteine protease, it also plays various roles in physiological conditions and diseases. However, its mechanism of degradation remains unclear. In the present study, we showed that the levels of BLH were significantly reduced during apoptosis induced by the antitumor agents bleomycin, etoposide and hydroxycamptothecin, and inhibited by the caspase inhibitors Q-VD-oph and Z-DEVD-FMK. Furthermore, the caspase-dependent cleavage of BLH was confirmed by cleavage of partly-purified human BLH with caspase-3 and caspase-9 in vitro. The stability of BLH at normal culture conditions was analyzed with the protein synthesis inhibitor cycloheximide and the proteasome inhibitor MG132. BLH was degraded at a rate lower than that of cyclin D1. This is the first report to demonstrate that BLH is cleaved by caspase-3 during apoptosis.

View Figures

View References

1	Chen J and Stubbe J: Bleomycins: towards better therapeutics. Nat Rev Cancer. 5:102–112. 2005. View Article : Google Scholar : PubMed/NCBI
2	Okamura Y, Nomoto S, Hayashi M, et al: Identification of the bleomycin hydrolase gene as a methylated tumor suppressor gene in hepatocellular carcinoma using a novel triple-combination array method. Cancer Lett. 312:150–157. 2011. View Article : Google Scholar : PubMed/NCBI
3	Towne CF, York IA, Watkin LB, Lazo JS and Rock KL: Analysis of the role of bleomycin hydrolase in antigen presentation and the generation of CD8 T cell responses. J Immunol. 178:6923–6930. 2007. View Article : Google Scholar : PubMed/NCBI
4	Suszynska J, Tisonczyk J, Lee HG, Smith MA and Jakubowski H: Reduced homocysteine-thiolactonase activity in Alzheimer’s disease. J Alzheimers Dis. 19:1177–1183. 2010.PubMed/NCBI
5	Lefterov IM, Koldamova RP and Lazo JS: Human bleomycin hydrolase regulates the secretion of amyloid precursor protein. FASEB J. 14:1837–1847. 2000. View Article : Google Scholar : PubMed/NCBI
6	Zimny J, Sikora M, Guranowski A and Jakubowski H: Protective mechanisms against homocysteine toxicity: the role of bleomycin hydrolase. J Biol Chem. 281:22485–22492. 2006. View Article : Google Scholar : PubMed/NCBI
7	Ratovitski T, Chighladze E, Waldron E, Hirschhorn RR and Ross CA: Cysteine proteases bleomycin hydrolase and cathepsin Z mediate N-terminal proteolysis and toxicity of mutant huntingtin. J Biol Chem. 286:12578–12589. 2011. View Article : Google Scholar : PubMed/NCBI
8	Kamata Y, Taniguchi A, Yamamoto M, Nomura J, Ishihara K, Takahara H, Hibino T and Takeda A: Neutral cysteine protease bleomycin hydrolase is essential for the breakdown of deiminated filaggrin into amino acids. J Biol Chem. 284:12829–12836. 2009. View Article : Google Scholar : PubMed/NCBI
9	Ferrando AA, Pendás AM, Llano E, Velasco G, Lidereau R and López-Otín C: Gene characterization, promoter analysis, and chromosomal localization of human bleomycin hydrolase. J Biol Chem. 272:33298–33304. 1997. View Article : Google Scholar : PubMed/NCBI
10	Ferrando AA, Velasco G, Campo E and Lopez-Otin C: Cloning and expression analysis of human bleomycin hydrolase, a cysteine proteinase involved in chemotherapy resistance. Cancer Res. 56:1746–1750. 1996.PubMed/NCBI
11	Brömme D, Rossi AB, Smeekens SP, Anderson DC and Payan DG: Human bleomycin hydrolase: molecular cloning, sequencing, functional expression, and enzymatic characterization. Biochemistry. 35:6706–6714. 1996.PubMed/NCBI
12	Montoya SE, Ferrell RE and Lazo JS: Genomic structure and genetic mapping of the human neutral cysteine protease bleomycin hydrolase. Cancer Res. 57:4191–4195. 1997.PubMed/NCBI
13	Chen J, Chen Y and He Q: Action of bleomycin is affected by bleomycin hydrolase but not by caveolin-1. Int J Oncol. 41:2245–2252. 2012.PubMed/NCBI
14	Lazo JS, Boland CJ and Schwartz PE: Bleomycin hydrolase activity and cytotoxicity in human tumors. Cancer Res. 42:4026–4031. 1982.PubMed/NCBI
15	Schwartz DR, Homanics GE, Hoyt DG, Klein E, Abernethy J and Lazo JS: The neutral cysteine protease bleomycin hydrolase is essential for epidermal integrity and bleomycin resistance. Proc Natl Acad Sci USA. 96:4680–4685. 1999. View Article : Google Scholar : PubMed/NCBI
16	De Haas EC, Zwart N, Meijer C, et al: Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer. J Clin Oncol. 26:1817–1823. 2008.PubMed/NCBI
17	Timmer JC and Salvesen GS: Caspase substrates. Cell Death Differ. 214:66–72. 2007. View Article : Google Scholar
18	Crawford ED and Wells JA: Caspase substrates and cellular remodeling. Annu Rev Biochem. 80:1055–1087. 2011. View Article : Google Scholar : PubMed/NCBI
19	Xu G, Cirilli M, Huang Y, Rich RL, Myszka DG and Wu H: Covalent inhibition revealed by the crystal structure of the caspase-8/p35 complex. Nature. 410:494–497. 2001. View Article : Google Scholar : PubMed/NCBI
20	Koldamova RP, Lefterov IM, DiSabella MT and Lazo JS: An evolutionarily conserved cysteine protease, human bleomycin hydrolase, binds to the human homologue of ubiquitin-conjugating enzyme 9. Mol Pharmacol. 54:954–961. 1998.PubMed/NCBI
21	Schwanhäusser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, et al: Global quantification of mammalian gene expression control. Nature. 473:337–342. 2011.
22	Pei Z, Calmels TP, Creutz CE and Sebti SM: Yeast cysteine proteinase gene ycp1 induces resistance to bleomycin in mammalian cells. Mol Pharmacol. 48:676–681. 1995.PubMed/NCBI
23	Montoya SE, Thiels E, Card JP and Lazo JS: Astrogliosis and behavioral changes in mice lacking the neutral cysteine protease bleomycin hydrolase. Neuroscience. 146:890–900. 2007. View Article : Google Scholar : PubMed/NCBI
24	Chaitanya GV, Steven AJ and Babu PP: PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun Signal. 8:312010. View Article : Google Scholar : PubMed/NCBI